Department of Psychology, University of New Mexico, Albuquerque, NM, United States of America; Center on Alcohol, Substance use, And Addictions (CASAA), University of New Mexico, Albuquerque, NM, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America; Division of Depression and Anxiety Disorders, McLean Hospital, Belmont, MA, United States of America.
Department of Psychology, University of New Mexico, Albuquerque, NM, United States of America.
J Subst Use Addict Treat. 2024 Aug;163:209394. doi: 10.1016/j.josat.2024.209394. Epub 2024 May 11.
There is a need to identify clinically meaningful non-abstinent endpoints for cocaine use disorder (CUD) clinical trials. In this study, we sought to replicate and extend prior work validating reductions in cocaine use frequency levels as an endpoint by examining associations between reductions in cocaine use frequency and long-term functioning outcomes.
We conducted a secondary analysis of two randomized clinical trials (N = 445; 77.5 % male; mean age = 42.18 years; 86.5 % Black, 10.8 % non-Hispanic white) that evaluated telephone-based continuing care for a 12- and 24-month period. Cocaine use frequency levels, measured with the Timeline Followback, were (1) abstinence (no past-month cocaine use), (2) low-frequency use (1-4 days of use/month), and (3) high-frequency use (5+ days of use/month).
Among those who completed the 12-month follow-up (n = 392), most reduced from high-frequency use at baseline to abstinence at the 12-month follow-up (n = 243; 62.0 %). An additional 21.2 % (n = 83) reported either high-to-low-frequency use (n = 35; 8.9 %) or low use-to-abstinence (n = 48; 12.2 %); 16.8 % of participants (n = 66) did not change or increased their cocaine frequency level. Compared to those who had no change/increases in frequency levels, at least a one-level reduction from baseline to 12-month follow-up (i.e., high-to-low-frequency use, high-to-abstinence, low-to-abstinence) was concurrently associated with lower levels of negative consequences at the 12-month follow-up and prospectively with lower levels of cocaine use and consequences at 24-month follow-up, with effect sizes in the medium-to-large range. Those who reduced to abstinence generally had fewer drug use consequences at the 12-month follow-up than those who reduced to a low-frequency level; however, these groups did not significantly differ on any outcomes at the 24-month follow-up.
Categorical reductions in cocaine use frequency levels, including those short of abstinence, are associated with less cocaine use and lower problem severity up to two years following treatment entry. Low-frequency cocaine use following the initial treatment phase does not appear to forebode worsening functioning, such as escalations in cocaine use.
需要确定可卡因使用障碍(CUD)临床试验中具有临床意义的非戒断终点。在这项研究中,我们试图复制和扩展先前验证减少可卡因使用频率水平作为终点的工作,通过检查减少可卡因使用频率与长期功能结果之间的关联。
我们对两项随机临床试验(N=445;77.5%为男性;平均年龄=42.18 岁;86.5%为黑人,10.8%为非西班牙裔白人)进行了二次分析,评估了为期 12 个月和 24 个月的基于电话的延续护理。使用时间表随访法测量可卡因使用频率水平,分为(1)戒断(过去一个月没有可卡因使用),(2)低频使用(每月使用 1-4 天)和(3)高频使用(每月使用 5 天以上)。
在完成 12 个月随访的人群中(n=392),大多数人从基线时的高频使用减少到 12 个月时的戒断(n=243;62.0%)。另外 21.2%(n=83)报告了高频到低频使用(n=35;8.9%)或低频到戒断(n=48;12.2%);16.8%的参与者(n=66)的可卡因使用频率水平没有变化或增加。与频率水平没有变化或增加的参与者相比,至少从基线到 12 个月随访时有一级下降(即高频到低频使用、高频到戒断、低频到戒断),在 12 个月随访时同时与较低的负面后果水平相关,并前瞻性地与 24 个月随访时较低的可卡因使用和后果水平相关,效应大小处于中等至较大范围。那些减少到戒断的人通常在 12 个月随访时的药物使用后果比减少到低频水平的人更少;然而,这两组在 24 个月随访时在任何结果上都没有显著差异。
可卡因使用频率水平的分类减少,包括低于戒断的水平,与治疗开始后两年内可卡因使用减少和问题严重程度降低相关。初始治疗阶段后低频可卡因使用似乎不会预示功能恶化,例如可卡因使用增加。